Search Results Search Sort by RelevanceMost Recent Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109. Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117. Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471. Personal Narrative Jul 2021 The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19 Dorothy Wall, MA Overly physicalist approaches to caring for patients are not likely to help them. AMA J Ethics. 2021;23(7):E590-595. doi: 10.1001/amajethics.2021.590. Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673. Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Case and Commentary Feb 2021 临床医生应如何应对会加剧卫生不平等性的语言障碍? Jason Espinoza(医学博士) and Sabrina , Derrington(医学博士、文学硕士、已获认证的医疗保健伦理顾问) AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 ¿Cómo deberían responder los médicos clínicos a las barreras idiomáticas que exacerban la inequidad sanitaria? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C AMA J Ethics. 2021;E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 医生和药剂师应如何合作促进服务不足群体的卫生公平? Sara Shahdoost Moghadam(药学博士) and Sandra Leal(药学博士、公共卫生硕士、经认证的糖尿病护理和教育专家) AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 ¿Cómo deben colaborar los médicos y farmacéuticos para motivar la equidad sanitaria en las comunidades desatendidas? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES AMA J Ethics. 2021;E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Feb 2021 How Should Clinicians Respond to Language Barriers That Exacerbate Health Inequity? Jason Espinoza, MD and Sabrina Derrington, MD, MA, HEC-C Limited language proficiency is a driver of health inequity and exacerbates other social determinants of health. AMA J Ethics. 2021;23(2):E109-116. doi: 10.1001/amajethics.2021.109.
Case and Commentary Feb 2021 How Should Physicians and Pharmacists Collaborate to Motivate Health Equity in Underserved Communities? Sara Shahdoost Moghadam, PharmD and Sandra Leal, PharmD, MPH, CDCES Physicians and pharmacists play key roles in addressing social determinants of health and health inequity. AMA J Ethics. 2021;23(2):E117-126. doi: 10.1001/amajethics.2021.117.
Case and Commentary Jun 2021 Pharmacist and Prescriber Responsibilities for Avoiding Prescription Drug Misuse Stephanie Sun, MD, MSc and Bruce D. White, DO, JD This commentary explores legal, ethical, and practical considerations for pharmacists and prescribers working together to address uncertainty in drug prescribing. AMA J Ethics. 2021;23(6):E471-479. doi: 10.1001/amajethics.2021.471.
Personal Narrative Jul 2021 The Importance of Listening in Treating Invisible Illness and Long-Haul COVID-19 Dorothy Wall, MA Overly physicalist approaches to caring for patients are not likely to help them. AMA J Ethics. 2021;23(7):E590-595. doi: 10.1001/amajethics.2021.590.
Case and Commentary Sep 2021 How Should Clinicians and Organizations Assess Risks and Benefits of First-in-Human Implantation of Investigational Devices? Beatrice L. Brown, MBE and Aaron S. Kesselheim, MD, JD, MPH Heightened caution, improved physician and patient communication, and equitable access are key priorities. AMA J Ethics. 2021;23(9):E673-678. doi: 10.1001/amajethics.2021.673.
Medical Education Sep 2021 What Should the Public Know About Implantable Material and Device Innovation in the US? Donna-Bea Tillman, PhD, MPA Device innovation has potential to improve patient outcomes over time, yet prospective benefits must be considered in light of risks. AMA J Ethics. 2021;23(9):E697-701. doi: 10.1001/amajethics.2021.697.